The Interaction of CORM-2 with Block Copolymers Containing Poly(4-vinylpyridine): Macromolecular Scaffolds for Carbon Monoxide Delivery in Biological Systems.

CORM-2, tricarbonyldichlororuthenium(II) dimer (Ru2 Cl4 (CO)6 ), is a common carbon monoxide releasing molecule (CORM) studied both in vitro and in vivo, but this compound possesses poor water solubility and a short half-life, which hinders its clinical development. Herein, for the first time the conjugation of CORM-2 is reported with a copolymer containing poly(4-vinylpyridine) to yield water-soluble CO-releasing polymeric nanoparticles. CORM-2 is rapidly conjugated to copolymers through pyridine groups as confirmed by inductively coupled plasma-optical emission spectroscopy and infrared spectroscopy. In comparison with free CORM-2, the copolymers functionalized with CORM-2 display better water solubility and the CO release from the polymer-based CORM is slow and sustained. This study paves the way for the potential use of a copolymer encapsulating CORM-2 as a therapeutic agent.

[1]  S. Rice,et al.  CO-Releasing Polymers Exert Antimicrobial Activity. , 2015, Biomacromolecules.

[2]  R. Poole,et al.  CO-releasing Metal Carbonyl Compounds as Antimicrobial Agents in the Post-antibiotic Era , 2015, The Journal of Biological Chemistry.

[3]  M. Stenzel,et al.  Origami with ABC Triblock Terpolymers Based on Glycopolymers: Creation of Virus-Like Morphologies. , 2015, ACS macro letters.

[4]  H. Maeda,et al.  Development of next-generation macromolecular drugs based on the EPR effect: challenges and pitfalls , 2015, Expert opinion on drug delivery.

[5]  A. Müller,et al.  Control of morphology and corona composition in aggregates of mixtures of PS-b-PAA and PS-b-P4VP diblock copolymers: effects of solvent, water content, and mixture composition. , 2014, Langmuir : the ACS journal of surfaces and colloids.

[6]  H. Maeda,et al.  Styrene-maleic acid copolymer-encapsulated CORM2, a water-soluble carbon monoxide (CO) donor with a constant CO-releasing property, exhibits therapeutic potential for inflammatory bowel disease. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[7]  Evgeny Katz,et al.  Self-powered electrochemical memristor based on a biofuel cell--towards memristors integrated with biocomputing systems. , 2014, Chemical communications.

[8]  L. Spiccia,et al.  Synthesis, spectroscopic properties, and photoinduced CO-release studies of functionalized ruthenium(II) polypyridyl complexes: versatile building blocks for development of CORM-peptide nucleic acid bioconjugates. , 2013, Inorganic chemistry.

[9]  R. Motterlini,et al.  Carbon Monoxide Reduces Neuropathic Pain and Spinal Microglial Activation by Inhibiting Nitric Oxide Synthesis in Mice , 2012, PloS one.

[10]  E. Denamur,et al.  Differential antibacterial activity against Pseudomonas aeruginosa by carbon monoxide-releasing molecules. , 2012, Antioxidants & redox signaling.

[11]  J. Hubbell,et al.  Carbon monoxide-releasing micelles for immunotherapy. , 2010, Journal of the American Chemical Society.

[12]  L. Otterbein,et al.  The therapeutic potential of carbon monoxide , 2010, Nature Reviews Drug Discovery.

[13]  William B. Liechty,et al.  Polymers for drug delivery systems. , 2010, Annual review of chemical and biomolecular engineering.

[14]  D. Stolz,et al.  Ex vivo Application of Carbon Monoxide in UW Solution Prevents Transplant‐Induced Renal Ischemia/Reperfusion Injury in Pigs , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[15]  T. Yoshikawa,et al.  Carbon Monoxide Liberated from CO-Releasing Molecule (CORM-2) Attenuates Ischemia/Reperfusion (I/R)-Induced Inflammation in the Small Intestine , 2010, Inflammation.

[16]  Fátima Al-Shahrour,et al.  Exploring the antimicrobial action of a carbon monoxide-releasing compound through whole-genome transcription profiling of Escherichia coli. , 2009, Microbiology.

[17]  M. Alcaraz,et al.  The CO-releasing molecule CORM-2 is a novel regulator of the inflammatory process in osteoarthritic chondrocytes. , 2008, Rheumatology.

[18]  L. M. Saraiva,et al.  Antimicrobial Action of Carbon Monoxide-Releasing Compounds , 2007, Antimicrobial Agents and Chemotherapy.

[19]  M. Alcaraz,et al.  The carbon monoxide‐releasing molecule CORM‐2 inhibits the inflammatory response induced by cytokines in Caco‐2 cells , 2007, British journal of pharmacology.

[20]  Junlian Huang,et al.  Synthesis and characterization of the novel block copolymer poly(ε-caprolactone)-b-poly(4-vinyl pyridine) by the combination of coordination and controlled free-radical polymerizations , 2004 .

[21]  C. Chan,et al.  Surface quantitative characterization of poly(styrene-co-4-vinyl phenol)/poly(styrene-co-4-vinyl pyridine) blends with controlled hydrogen bonding interactions , 2004 .

[22]  B. Panunzi,et al.  Poly(4‐vinylpyridine) as the host ligand of metal‐containing chromophores for second‐order nonlinear optical active materials , 2002 .

[23]  C. Chan,et al.  Surface Characterization of Poly(styrene-co-p-hexafluoro- hydroxyisopropyl-α-methylstyrene)/Poly(4-vinylpyridine) Blends Spanning the Immiscibility-Miscibility-Complexation Transition by XPS, ToF-SIMS, and AFM , 2002 .

[24]  O. Pillai,et al.  Polymers in drug delivery. , 2001, Current opinion in chemical biology.

[25]  Guangzhao Zhang,et al.  Soluble graft-like complexes based on poly(4-vinyl pyridine) and carboxy-terminated polystyrene oligomers due to hydrogen bonding , 1999 .

[26]  H. Maeda,et al.  The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. , 2013, Advanced drug delivery reviews.

[27]  R. Potter,et al.  Carbon monoxide liberated from carbon monoxide-releasing molecule CORM-2 attenuates inflammation in the liver of septic mice. , 2008, American journal of physiology. Gastrointestinal and liver physiology.